BMY – Welcome to stockcalc’s blog archive. We’ve launched a new blog! Visit us here.

Gilead Sciences (GILD:NAS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Gilead Sciences(GILD:NAS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$63.84 (USD) 04/29/2021 Weighted Valuation$68.09 (USD) Overall RatingUndervalued by 6.7% Valuation Models Comparables: $67.83 …

Gilead Sciences (GILD:NAS) Fundamental Valuation Report Read more »

Bristol-Myers Squibb (BMY:NYS) and Telefonica (TEF:NYS) Downgraded

By Brian Donovan Posted on May 22, 2019 Posted in Downgraded Stocks

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Bristol-Myers Squibb (BMY:NYS) and Telefonica (TEF:NYS) Downgraded Read more »

AbbVie (ABBV:NYS) Fundamental Valuation Report

By admin Posted on March 1, 2019 Posted in Uncategorised

Fundamental Valuation Report AbbVie(ABBV:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$79.24 (USD) 28/02/2019 Weighted Valuation$92.73 (USD) Overall RatingUndervalued by 17.0% Valuation Models Analyst Consensus: $92.73 (USD) (in …

AbbVie (ABBV:NYS) Fundamental Valuation Report Read more »

Bristol-Myers Squibb (BMY:NYS) Fundamental Valuation Report

By admin Posted on February 27, 2019 Posted in Uncategorised

Fundamental Valuation Report Bristol-Myers Squibb(BMY:NYS) Healthcare:Drug Manufacturers-Major This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$50.16 (USD) 26/02/2019 Weighted Valuation$57.99 (USD) Overall RatingUndervalued by 15.6% Valuation Models Analyst Consensus: $58.00 (USD) …

Bristol-Myers Squibb (BMY:NYS) Fundamental Valuation Report Read more »